Thyroid-Associated Ophthalmopathy Subtypes and Orbital Antibodies

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 31, 2003

Study Completion Date

January 31, 2006

Conditions
Graves' Ophthalmopathy
Interventions
DRUG

Carbimazole, radio-active iodine (I131)

Trial Locations (1)

3220

Barwon Health - The Geelong Hospital, Geelong

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

University of Melbourne

OTHER

collaborator

National Health and Medical Research Council, Australia

OTHER

lead

Barwon Health

OTHER_GOV